��������

Colin Miller, PhD, FIPEM, CSci, is an accomplished professional in the life sciences and clinical research sectors, currently serving as CEO and Founder of The Bracken Group, which specializes in life sciences consulting, digital marketing, and analytics since March 2015. Colin also holds the position of Head of Clinical Operations and Regulatory Affairs at CytoSite Bio, focusing on precision imaging products in radiopharmaceuticals. Previous roles include Partner at Alacrita and Senior Vice President at BioClinica, where significant contributions were made to business development, medical affairs, and strategic development. Colin's extensive experience dates back to founding Bona Fide Ltd. and working with Procter & Gamble Pharmaceuticals, where expertise in clinical trials and medical imaging was developed. Colin earned a BSc (HONS) in Physiology and Zoology from The University of Sheffield and a PhD from the University of Hull.